Health Care Industry News – Health Care Articles – Health Care Information #pharmaceutical #suppliers


Posted On Dec 2 2017 by

#healthcare industry news

#

Health Care

Plenty of other drug companies have been raising their prices.

8:23 a.m. Sept. 2, 2016

Merck & Co. said Friday it is scrapping the development of osteoporosis treatment odanacatib and will no longer seek regulatory approval for its use. “We are disappointed that the overall benefit-risk profile for odanacatib does not support filing or further development,” said Roger M. Perlmutter, M.D. Ph.D. president, Merck Research Laboratories. An independent review of the drug confirmed an increased risk of stroke, the company said in a statement. Merck shares were not yet active in premarket trade, but are up 19% in the year so far, while the S 2016 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Terms of Service. Privacy Policy and Cookie Policy.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. Intraday data delayed per exchange requirements. S
/* 728×90, создано 05.02.11 */
google_ad_slot = “6127977750”;
google_ad_width = 670;
google_ad_height = 90;
//–>

Last Updated on: December 2nd, 2017 at 5:47 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *